D. Casimiro

发表

Design of an HA2-based Escherichia coli expressed influenza immunogen that protects mice from pathogenic challenge

R. Varadarajan, J. Shiver, M. Citron, 2010, Proceedings of the National Academy of Sciences.

A Tetravalent Sub-unit Dengue Vaccine Formulated with Ionizable Cationic Lipid Nanoparticle induces Significant Immune Responses in Rodents and Non-Human Primates

Marian E. Gindy, D. Casimiro, A. Bett, 2016, Scientific Reports.

Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity

Henryk Mach, Norman L. Letvin, Michelle A. Lifton, 2002, Nature.

Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial

Devan V Mehrotra, Ann Duerr, Peter B Gilbert, 2008, The Lancet.

Detection of HIV Vaccine-Induced Cell-Mediated Immunity in HIV-Seronegative Clinical Trial Participants Using an Optimized and Validated Enzyme-Linked Immunospot Assay

Devan Mehrotra, Christine Gaunt, Robin Mogg, 2007, Journal of acquired immune deficiency syndromes.

IMPre: An Accurate and Efficient Software for Prediction of T- and B-Cell Receptor Germline Genes and Alleles from Rearranged Repertoire Data

Wei Zhang, I-Ming Wang, Jinghua Wu, 2016, Front. Immunol..

Pre-vaccination inflammation and B-cell signalling predict age-related hyporesponse to hepatitis B vaccination

I-Ming Wang, Razvan Cristescu, I. Wang, 2016, Nature Communications.

Immune response and reactogenicity of an unadjuvanted intradermally delivered human papillomavirus vaccine using a first generation Nanopatch™ in rhesus macaques: An exploratory, pre-clinical feasibility assessment

R. K. Evans, M. Kendall, D. Casimiro, 2019, Vaccine: X.

HIV-1 vaccine-induced immunity in the test-of-concept Step Study: a case–cohort analysis

Donald K Carter, Holly Janes, Devan V Mehrotra, 2008, The Lancet.

Adenovirus-Specific Immunity Following Immunization with an Ad5 HIV-1 Vaccine Candidate in Humans

M. Betts, M. Lifton, J. Shiver, 2009, Nature Medicine.

RATES OF HEME OXIDATION AND REDUCTION IN RU(HIS33)CYTOCHROME C AT VERY HIGH DRIVING FORCES

H. Gray, M. Hill, J. Winkler, 1996 .

A novel lipid nanoparticle adjuvant significantly enhances B cell and T cell responses to sub-unit vaccine antigens.

Marian E. Gindy, K. Vora, D. Casimiro, 2016, Vaccine.

Immunogenicity of a reduced-dose whole killed rabies vaccine is significantly enhanced by ISCOMATRIX™ adjuvant, Merck amorphous aluminum hydroxylphosphate sulfate (MAA) or a synthetic TLR9 agonist in rhesus macaques.

D. Casimiro, J. T. ter Meulen, A. Bett, 2013, Vaccine.

Design and optimization of a multiplex anti-influenza peptide immunoassay.

J. Drummond, A. Finnefrock, Xiao-ping Liang, 2008, Journal of immunological methods.

Antigen levels and antibody titers after DNA vaccination.

A. Simon, C. R. Middaugh, D. Holder, 2001, Journal of pharmaceutical sciences.

Evaluation of heterologous prime-boost vaccination strategies using chimpanzee adenovirus and modified vaccinia virus for TB subunit vaccination in rhesus macaques

H. J. Borish, F. Verreck, Dominick J. Laddy, 2020, npj Vaccines.

Safety and immunogenicity of a replication-incompetent adenovirus type 5 HIV-1 clade B gag/pol/nef vaccine in healthy adults.

J. Kublin, D. Mehrotra, J. Shiver, 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

A potent broadly neutralizing human RSV antibody targets conserved site IV of the fusion glycoprotein

H. Su, K. Vora, M. Eddins, 2019, Nature Communications.

Sustained Peptide-Specific Gamma Interferon T-Cell Response in Rhesus Macaques Immunized with Human Immunodeficiency Virus gag DNA Vaccines

R. K. Evans, A. Simon, J. Shiver, 2002, Journal of Virology.

Safety and Immunogenicity of the Merck Adenovirus Serotype 5 (MRKAd5) and MRKAd6 Human Immunodeficiency Virus Type 1 Trigene Vaccines Alone and in Combination in Healthy Adults

D. Mehrotra, J. Shiver, R. Leavitt, 2009, Clinical and Vaccine Immunology.

International epidemiology of human pre-existing adenovirus (Ad) type-5, type-6, type-26 and type-36 neutralizing antibodies: correlates of high Ad5 titers and implications for potential HIV vaccine trials.

N. Wolfe, J. Shiver, W. Straus, 2010, Vaccine.

Mamu-A*01 Allele-Mediated Attenuation of Disease Progression in Simian-Human Immunodeficiency Virus Infection

J. Shiver, W. Schleif, E. Emini, 2002, Journal of Virology.

Long-Range Electron Transfer in Ruthenium-Modified Cytochromes c. σ-Tunneling Pathways through Aromatic Residues

H. Gray, J. Richards, J. Winkler, 1993 .

Gene synthesis, high-level expression, and mutagenesis of Thiobacillus ferrooxidans rusticyanin: His 85 is a ligand to the blue copper center.

H. Dyson, D. Casimiro, R. Blake, 1995, Biochemistry.

Enhancing B- and T-Cell Immune Response to a Hepatitis C Virus E2 DNA Vaccine by Intramuscular Electrical Gene Transfer

A. Folgori, R. Cortese, A. Nicosia, 2000, Journal of Virology.

Human adenovirus-specific T cells modulate HIV-specific T cell responses to an Ad5-vectored HIV-1 vaccine.

Allan C. deCamp, J. Kublin, S. Buchbinder, 2012, The Journal of clinical investigation.

DNA vaccines targeting heavy chain C-terminal fragments of Clostridium botulinum neurotoxin serotypes A, B, and E induce potent humoral and cellular immunity and provide protection from lethal toxin challenge

N. Sardesai, D. Weiner, Jian Yan, 2015, Human vaccines & immunotherapeutics.

Effector and Central Memory Poly-Functional CD4+ and CD8+ T Cells are Boosted upon ZOSTAVAX® Vaccination

K. Vora, D. Casimiro, K. Cox, 2015, Front. Immunol..

Preclinical development of a dengue tetravalent recombinant subunit vaccine: Immunogenicity and protective efficacy in nonhuman primates.

D. Clements, D. Casimiro, J. T. ter Meulen, 2015, Vaccine.

Evaluating functional antibodies in rhesus monkeys immunized with hepatitis B virus surface antigen vaccine with novel adjuvant formulations.

Qinjian Zhao, Victoria Towne, D. Casimiro, 2011, Vaccine.

Robust, vaccine-induced CD8(+) T lymphocyte response against an out-of-frame epitope.

D. Watkins, M. Citron, Xiao-ping Liang, 2010, Journal of immunology.

Synthesis and immunological activities of novel agonists of toll-like receptor 9.

M. Struthers, Hao Wang, Dong Yu, 2010, Cellular immunology.

Characterizations of four monoclonal antibodies against M2 protein ectodomain of influenza A virus.

J. Shiver, V. Garsky, Qinjian Zhao, 2009, Virology.

Live Attenuated Herpes Simplex Virus 2 Glycoprotein E Deletion Mutant as a Vaccine Candidate Defective in Neuronal Spread

J. Lubinski, H. Friedman, J. W. Balliet, 2012, Journal of Virology.

The promise of mRNA vaccines: a biotech and industrial perspective

S. Gurunathan, F. Derosa, D. Casimiro, 2020, npj Vaccines.

Comparative analysis of the effects of packaging signal, transgene orientation, promoters, polyadenylation signals, and E3 region on growth properties of first-generation adenoviruses.

T. Toner, J. Shiver, E. Emini, 2003, Human gene therapy.

Quantitative analysis of neutralizing antibody response to human cytomegalovirus in natural infection.

A. Finnefrock, Fengsheng Li, D. Casimiro, 2011, Vaccine.

A novel high-throughput neutralization assay for supporting clinical evaluations of human cytomegalovirus vaccines.

A. Finnefrock, Fengsheng Li, D. Casimiro, 2011, Vaccine.

Restoration of viral epithelial tropism improves immunogenicity in rabbits and rhesus macaques for a whole virion vaccine of human cytomegalovirus.

J. Shiver, A. Finnefrock, Fengsheng Li, 2012, Vaccine.

T-cell response to adenovirus hexon and DNA-binding protein in mice

D. Casimiro, M. Chastain, A. Bett, 2004, Gene Therapy.

Synthesis and immunological activities of novel Toll-like receptor 7 and 8 agonists.

M. Struthers, S. Agrawal, D. Casimiro, 2011, Cellular immunology.

Electron transfer in ruthenium/zinc porphyrin derivatives of recombinant human myoglobins. Analysis of tunneling pathways in myoglobin and cytochrome c

H. Gray, J. Richards, L. Wong, 1993 .

Functionally inactivated dominant viral antigens of human cytomegalovirus delivered in replication incompetent adenovirus type 6 vectors as vaccine candidates

Fengsheng Li, D. Casimiro, T. Fu, 2017, Human vaccines & immunotherapeutics.

An optimized SIV DNA vaccine can serve as a boost for Ad5 and provide partial protection from a high-dose SIVmac251 challenge.

Christopher J. Miller, N. Sardesai, J. Kim, 2012, Vaccine.

Vaccination with Ad5 Vectors Expands Ad5-Specific CD8+ T Cells without Altering Memory Phenotype or Functionality

M. Betts, H. Ertl, D. Carnathan, 2010, PloS one.

Development of stable liquid formulations for adenovirus-based vaccines.

R. K. Evans, J. Shiver, D. Volkin, 2004, Journal of pharmaceutical sciences.

Characterization of prefusion-F-specific antibodies elicited by natural infection with human metapneumovirus

E. Chautard, J. McLellan, C. Hsieh, 2022, bioRxiv.

Progress and challenges in TB vaccine development [version 1; peer review: 2 approved]

S. Kaufmann, M. Hatherill, H. McShane, 2021 .

Control of viremia and prevention of clinical AIDS in rhesus monkeys by cytokine-augmented DNA vaccination.

A. Simon, A. Craiu, D. Montefiori, 2000, Science.

High-resolution solution structure of the retinoid X receptor DNA-binding domain.

H. Dyson, P. Wright, D. Sem, 1998, Journal of molecular biology.

A Herpes Simplex Virus 2 (HSV-2) Glycoprotein D-expressing Nonreplicating Dominant-Negative HSV-2 Virus Vaccine Is Superior to a gD2 Subunit Vaccine against HSV-2 Genital Infection in Guinea Pigs

J. W. Balliet, D. Casimiro, Pengwei Zhang, 2014, PloS one.

Enhanced Production of Chikungunya Virus-Like Particles Using a High-pH Adapted Spodoptera frugiperda Insect Cell Line

James M. Wagner, Christopher L. Daniels, L. F. Ng, 2014, PloS one.

Characterization of N-glycosylation profiles from mammalian and insect cell derived chikungunya VLP.

R. Rustandi, R. Schwartz, D. Casimiro, 2016, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

Analysis of plasmid DNA from a pharmaceutical perspective.

R. K. Evans, D. Casimiro, D. Montgomery, 1998, Journal of pharmaceutical sciences.

Integrase Inhibitors and Cellular Immunity Suppress Retroviral Replication in Rhesus Macaques

D. Hazuda, J. Shiver, W. Schleif, 2004, Science.

Cu(II)‐Binding properties of a cytochrome c with a synthetic metal‐binding site: His‐X3‐His in an α‐helix

F. Arnold, D. Casimiro, B. Haymore, 1991, Proteins.

Prevention of tuberculosis in macaques after intravenous BCG immunization

M. Wadsworth, T. Hughes, A. Shalek, 2020, Nature.

Construction of an rtTA2s-m2/ttskid-Based transcription regulatory switch that displays no basal activity, good inducibility, and high responsiveness to doxycycline in mice and Non-Human primates

R. Cortese, A. Simon, H. Bujard, 2003 .

Construction of an rtTA2(s)-m2/tts(kid)-based transcription regulatory switch that displays no basal activity, good inducibility, and high responsiveness to doxycycline in mice and non-human primates.

R. Cortese, A. Simon, H. Bujard, 2003, Molecular therapy : the journal of the American Society of Gene Therapy.

Comparative analysis of immune responses induced by vaccination with SIV antigens by recombinant Ad5 vector or plasmid DNA in rhesus macaques.

N. Sardesai, J. Kim, D. Weiner, 2010, Molecular therapy : the journal of the American Society of Gene Therapy.

Synthesizing Vaccines with Microbes

D. Casimiro, M. Wacker, 2012 .

Comparative Immunogenicity in Rhesus Monkeys of DNA Plasmid, Recombinant Vaccinia Virus, and Replication-Defective Adenovirus Vectors Expressing a Human Immunodeficiency Virus Type 1 gag Gene

R. K. Evans, T. Toner, J. Shiver, 2003, Journal of Virology.

Vaccine-induced gag-specific T cells are associated with reduced viremia after HIV-1 infection.

N. Frahm, M. McElrath, P. Gilbert, 2013, The Journal of infectious diseases.

NMR Spectroscopic Studies of the DNA-binding Domain of the Monomer-binding Nuclear Orphan Receptor, Human Estrogen Related Receptor-2

S. Kliewer, P. Wright, R. Evans, 1997, The Journal of Biological Chemistry.

A trivalent recombinant Ad5 gag/pol/nef vaccine fails to protect rhesus macaques from infection or control virus replication after a limiting-dose heterologous SIV challenge.

D. Watkins, J. Lifson, W. Koff, 2012, Vaccine.

AIDS clinical trials group 5197: a placebo-controlled trial of immunization of HIV-1-infected persons with a replication-deficient adenovirus type 5 vaccine expressing the HIV-1 core protein.

R. Schooley, M. Lederman, D. Kuritzkes, 2010, The Journal of infectious diseases.

Vaccine-Induced Cellular Immune Responses Reduce Plasma Viral Concentrations after Repeated Low-Dose Challenge with Pathogenic Simian Immunodeficiency Virus SIVmac239

Jiang Fan, Amit Patki, Jason Reed, 2006, Journal of Virology.

The promise of mRNA vaccines: a biotech and industrial perspective

S. Gurunathan, F. Derosa, D. Casimiro, 2020, npj Vaccines.

Antibodies to the Buried N Terminus of Rhinovirus VP4 Exhibit Cross-Serotypic Neutralization

T. Smith, D. Casimiro, T. Fu, 2009, Journal of Virology.

Protection Provided by a Herpes Simplex Virus 2 (HSV-2) Glycoprotein C and D Subunit Antigen Vaccine against Genital HSV-2 Infection in HSV-1-Seropositive Guinea Pigs

Harvey M. Friedman, Maya S. Salnikova, Sita Awasthi, 2013, Journal of Virology.

Host genetic determinants of T cell responses to the MRKAd5 HIV-1 gag/pol/nef vaccine in the step trial.

K. Shianna, D. Goldstein, B. Haynes, 2011, The Journal of infectious diseases.

P08-06 LB. A genome-wide association study of host genetic determinants of T cell responses to the MRKAd5 HIV-1 gag/pol/nef vaccine in the STEP trial

K. Shianna, J. Fellay, N. Frahm, 2009, Retrovirology.

HIV-1 Vaccine-Induced T-Cell Reponses Cluster in Epitope Hotspots that Differ from Those Induced in Natural Infection with HIV-1

T. Hertz, S. Self, S. Buchbinder, 2013, PLoS pathogens.

Baseline Ad5 serostatus does not predict Ad5-HIV vaccine-induced expansion of Ad-specific CD4+ T-cells

M. Betts, H. Ertl, D. Carnathan, 2009, Nature Medicine.

Hexon gene switch strategy for the generation of chimeric recombinant adenovirus.

T. Toner, D. Casimiro, A. Bett, 2002, Human gene therapy.

Attenuation of Simian Immunodeficiency Virus SIVmac239 Infection by Prophylactic Immunization with DNA and Recombinant Adenoviral Vaccine Vectors Expressing Gag

D. Watkins, D. O’Connor, J. Shiver, 2005, Journal of Virology.

Role of nonhuman primates in the evaluation of candidate AIDS vaccines: an industry perspective

S. Staprans, M. Feinberg, J. Shiver, 2010, Current opinion in HIV and AIDS.

Cytotoxic T-Lymphocyte Escape Does Not Always Explain the Transient Control of Simian Immunodeficiency Virus SIVmac239 Viremia in Adenovirus-Boosted and DNA-Primed Mamu-A*01-Positive Rhesus Macaques

Kendall C. Krebs, D. Watkins, D. O’Connor, 2005, Journal of Virology.

Quantitative adenovirus neutralization assays based on the secreted alkaline phosphatase reporter gene: application in epidemiologic studies and in the design of adenovector vaccines.

P. S. Bennett, J. Shiver, D. Casimiro, 2004, Human gene therapy.

Safety and Immunogenicity of the MRKAd5 gag HIV Type 1 Vaccine in a Worldwide Phase 1 Study of Healthy Adults.

S. Hammer, J. Kublin, S. Self, 2010, AIDS research and human retroviruses.

Vaccine-Induced Cellular Responses Control Simian Immunodeficiency Virus Replication after Heterologous Challenge

D. Watkins, J. Lifson, G. Shaw, 2009, Journal of Virology.

Protective antibodies elicited by SARS-CoV-2 spike protein vaccination are boosted in the lung after challenge in nonhuman primates

B. Haynes, D. Douek, N. Sullivan, 2021, Science Translational Medicine.

Vaccination with SARS-CoV-2 Spike Protein and AS03 Adjuvant Induces Rapid Anamnestic Antibodies in the Lung and Protects Against Virus Challenge in Nonhuman Primates

B. Haynes, D. Douek, N. Sullivan, 2021, bioRxiv.

Vectored Gag and Env but Not Tat Show Efficacy against Simian-Human Immunodeficiency Virus 89.6P Challenge in Mamu-A*01-Negative Rhesus Monkeys

J. Shiver, W. Schleif, L. Gabryelski, 2005, Journal of Virology.

The Number of Toll-Like Receptor 9-Agonist Motifs in the Adenovirus Genome Correlates with Induction of Dendritic Cell Maturation by Adenovirus Immune Complexes

G. Pantaleo, A. Harari, J. Gall, 2012, Journal of Virology.

Comparative cell-mediated immunogenicity of DNA/DNA, DNA/adenovirus type 5 (Ad5), or Ad5/Ad5 HIV-1 clade B gag vaccine prime-boost regimens.

J. Kublin, C. del Rio, D. Mehrotra, 2010, The Journal of infectious diseases.

PD-1 Blockade in Rhesus Macaques: Impact on Chronic Infection and Prophylactic Vaccination

D. Hazuda, J. Shiver, A. Finnefrock, 2009, The Journal of Immunology.

An efficient T-cell epitope discovery strategy using in silico prediction and the iTopia assay platform

G. Ciliberto, A. Finnefrock, N. La Monica, 2012, Oncoimmunology.

Structurally engineered cytochromes with unusual ligand-binding properties: expression of Saccharomyces cerevisiae Met-80-->Ala iso-1-cytochrome c.

J. Richards, D. Casimiro, H. B. Gray, 1993, Proceedings of the National Academy of Sciences of the United States of America.

Winning a Race Against Evolving Pathogens with Novel Platforms and Universal Vaccines

J. Heinrichs, J. Meulen, D. Casimiro, 2015 .

Heterologous Human Immunodeficiency Virus Type 1 Priming-Boosting Immunization Strategies Involving Replication-Defective Adenovirus and Poxvirus Vaccine Vectors

J. Shiver, E. Emini, S. Gurunathan, 2004, Journal of Virology.

Genetic impact of vaccination on breakthrough HIV-1 sequences from the Step trial

Peter B. Gilbert, Ann Duerr, Lawrence Corey, 2011, Nature Medicine.

DNA gag/Adenovirus Type 5 (Ad5) gag and Ad5 gag/Ad5 gag Vaccines Induce Distinct T-Cell Response Profiles

J. Shiver, D. Casimiro, K. Cox, 2008, Journal of Virology.

A comparison of standard immunogenicity assays for monitoring HIV type 1 gag-specific T cell responses in Ad5 HIV Type 1 gag vaccinated human subjects.

Devan V Mehrotra, Robin Mogg, D. Mehrotra, 2006, AIDS research and human retroviruses.

Immunogenicity and efficacy of mRNA COVID-19 vaccine MRT5500 in preclinical animal models

F. Derosa, D. Casimiro, T. Fu, 2021, npj Vaccines.

Immunogenicity and efficacy of mRNA COVID-19 vaccine MRT5500 in preclinical animal models

F. Derosa, D. Casimiro, T. Fu, 2021, NPJ vaccines.

Vaccine-Induced Immune Responses in Rodents and Nonhuman Primates by Use of a Humanized Human Immunodeficiency Virus Type 1 pol Gene

D. Richman, A. Simon, D. Havlir, 2002, Journal of Virology.

Vaccinationon Chronic Infection and Prophylactic PD-1 Blockade in Rhesus Macaques: Impact

D. Hazuda, J. Shiver, A. Finnefrock, 2008 .

Pre-Existing Adenovirus Immunity Modifies a Complex Mixed Th1 and Th2 Cytokine Response to an Ad5/HIV-1 Vaccine Candidate in Humans

S. Hammer, J. Kublin, M. McElrath, 2011, PloS one.

Cross-Clade Reactivity of HIV-1-Specific T-cell Responses in HIV-1-Infected Individuals From Botswana and Cameroon

D. Burke, N. Wolfe, J. Shiver, 2006, Journal of acquired immune deficiency syndromes.

Co-Administration of Lipid Nanoparticles and Sub-Unit Vaccine Antigens Is Required for Increase in Antigen-Specific Immune Responses in Mice

Marian E. Gindy, D. Casimiro, A. Bett, 2016, Vaccines.

Efficacy of Multivalent Adenovirus-Based Vaccine against Simian Immunodeficiency Virus Challenge

D. Watkins, D. O’Connor, J. Shiver, 2009, Journal of Virology.

Pan-SARS neutralizing responses after third boost vaccination in non-human primate immunogenicity model

F. Derosa, D. Casimiro, T. Fu, 2022, Vaccine.

Safety and immunogenicity of adenovirus-vectored near-consensus HIV type 1 clade B gag vaccines in healthy adults.

D. Mehrotra, M. Mulligan, J. Shiver, 2009, AIDS research and human retroviruses.

Evaluation of heterologous prime-boost vaccination strategies using chimpanzee adenovirus and modified vaccinia virus for TB subunit vaccination in rhesus macaques

H. J. Borish, F. Verreck, Dominick J. Laddy, 2020, npj Vaccines.

Vaccine-Induced Immunity in Baboons by Using DNA and Replication-Incompetent Adenovirus Type 5 Vectors Expressing a Human Immunodeficiency Virus Type 1 gag Gene

R. K. Evans, J. Shiver, E. Emini, 2003, Journal of Virology.

Mapping HIV-1 Vaccine Induced T-Cell Responses: Bias towards Less-Conserved Regions and Potential Impact on Vaccine Efficacy in the Step Study

B. Korber, S. Self, M. McElrath, 2011, PloS one.

Comparison of T cell immune responses induced by vectored HIV vaccines in non-human primates and humans.

D. Mehrotra, J. Shiver, S. Gurunathan, 2010, Vaccine.

Discovery and Characterization of Phage Display-Derived Human Monoclonal Antibodies against RSV F Glycoprotein

K. Vora, C. Callahan, D. Casimiro, 2016, PloS one.

Low-Dose Penile SIVmac251 Exposure of Rhesus Macaques Infected with Adenovirus Type 5 (Ad5) and Then Immunized with a Replication-Defective Ad5-Based SIV gag/pol/nef Vaccine Recapitulates the Results of the Phase IIb Step Trial of a Similar HIV-1 Vaccine

J. Shiver, L. Fritts, P. Gilbert, 2011, Journal of Virology.

The impact of early immune destruction on the kinetics of postacute viral replication in rhesus monkey infected with the simian-human immunodeficiency virus 89.6P.

B. Connolly, J. Shiver, W. Schleif, 2004, Virology.

Ruthenium-mediated protein cross-linking and stabilization

Frances H. Arnold, Harry B. Gray, F. Arnold, 1993 .

Development of multivalent mRNA vaccine candidates for seasonal or pandemic influenza

F. Derosa, Sophia T. Mundle, D. Casimiro, 2021, NPJ vaccines.

Progress and challenges in TB vaccine development

S. Kaufmann, M. Hatherill, H. McShane, 2018, F1000Research.

Efficient generation of monoclonal antibodies from single rhesus macaque antibody secreting cells

Xue-jun Fan, J. Joyce, D. Casimiro, 2015, mAbs.

Pentameric complex of viral glycoprotein H is the primary target for potent neutralization by a human cytomegalovirus vaccine

Amy S. Espeseth, A. Espeseth, J. Shiver, 2013, Proceedings of the National Academy of Sciences.

Immune cell phenotypes associated with disease severity and long-term neutralizing antibody titers after natural dengue virus infection

B. Lim, T. Yeo, L. Tucker-Kellogg, 2021, Cell reports. Medicine.

Electron spin echo modulation study of the Type I copper protein rusticyanin and its mutant variant His85Ala

H. Dyson, D. Casimiro, C. Bender, 1997 .

The effect of early versus delayed challenge after vaccination in controlling SHIV 89.6P infection.

Leslie L. Chavez, A. Perelson, M. Davenport, 2008, Virology.

Development of multivalent mRNA vaccine candidates for seasonal or pandemic influenza

F. Derosa, Sophia T. Mundle, D. Casimiro, 2021, npj Vaccines.

Electron transfer in cytochromes C with chelated ruthenium(II) polypyridine complexes.

F. Arnold, H. Gray, J. Richards, 1993 .

Electron transfer in ruthenium-modified recombinant cytochromes and myoglobins

D. Casimiro, 1994 .

Immunogenicity of novel mRNA COVID-19 vaccine MRT5500 in mice and non-human primates

F. Derosa, D. Casimiro, T. Fu, 2020, bioRxiv.

Early depletion of proliferating B cells of germinal center in rapidly progressive simian immunodeficiency virus infection.

J. Shiver, W. Schleif, E. Emini, 2007, Virology.

Enhanced rates and magnitude of immune responses detected against an HIV vaccine: effect of using an optimized process for isolating PBMC.

D. Mehrotra, J. Shiver, R. Mogg, 2007, AIDS research and human retroviruses.

Preclinical and clinical development of a dengue recombinant subunit vaccine.

D. E. Parks, D. Clements, D. Casimiro, 2015, Vaccine.

Corrigendum: Baseline Ad5 serostatus does not predict Ad5 HIV vaccine–induced expansion of adenovirus-specific CD4+ T cells

M. Betts, H. Ertl, D. Carnathan, 2009, Nature Medicine.

PCR-based gene synthesis and protein NMR spectroscopy.

P E Wright, H. Dyson, P. Wright, 1997, Structure.

Potent neutralizing antibodies elicited by dengue vaccine in rhesus macaque target diverse epitopes

Qihui Wang, K. Vora, B. Doranz, 2019, PLoS pathogens.

A replication-defective human cytomegalovirus vaccine for prevention of congenital infection

Jingyuan Xu, Dai Wang, Amy S. Espeseth, 2016, Science Translational Medicine.

Estimating the Impact of Vaccination on Acute Simian-Human Immunodeficiency Virus/Simian Immunodeficiency Virus Infections

J. Petravic, M. Davenport, R. Ribeiro, 2008, Journal of Virology.

Genetic vaccination by gene electro-transfer in non-human primates

A. Folgori, R. Cortese, A. Nicosia, 2006 .

Structure of a glycerol-conducting channel and the basis for its selectivity.

D. Fu, A. Libson, L. Miercke, 2000, Science.

Rapid isolation of dengue-neutralizing antibodies from single cell-sorted human antigen-specific memory B-cell cultures

K. Vora, B. Doranz, D. Casimiro, 2015, mAbs.

Development and application of a reversed-phase high-performance liquid chromatographic method for quantitation and characterization of a Chikungunya virus-like particle vaccine.

D. Casimiro, S. Ha, Richard M. Schwartz, 2014, Journal of chromatography. A.

Characterization and biological evaluation of a microparticle adjuvant formulation for plasmid DNA vaccines.